T cell receptor transgenic mice provide novel insights into understanding cellular targets of TCDD: Suppression of antibody production, but not the response of CD8+ T cells, during infection with influenza virus

Toxicology and Applied Pharmacology

Volumn 192, Issue 3, 2003, Pages 275-286

  Mitchell, Kristen A ^a   Lawrence, B Paige ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin (TCDD); Immunotoxicity; Influenza virus; T cell receptor; Transgenic mice

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOKINE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VIRUS A; LUNG FUNCTION; LYMPH NODE; MOLECULAR CLONING; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; WILD TYPE;

INFLUENZA A VIRUS; INFLUENZA VIRUS; MUS MUSCULUS;

EID: 0142185091     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00297-7     Document Type: Article

References (62)

1. Allan W., Tabi Z., Cleary A., Doherty P.C. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J. Immunol. 144:(10):1990;3980-3986.
2. Barrett T., Inglis S. Growth, purification and titration of influenza viruses. Mahy B.W.J. Virology A Practical Approach . 1985;119-150 IRL Press, Oxford.
3. Bender B.S., Croghan T., Zhang L., Small P.A. Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175:(4):1992;1143-1145.
4. Blattman J.N., Antia R., Sourdive D.J., Wang X., Kaech S.M., Murali-Krishna K., Altman J.D., Ahmed R. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:(5):2002;657-664.
5. Burleson G., Lebrec H., Yang Y., Ibanes J., Pennington K., Birnbaum L. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice. Fundam. Appl. Toxicol. 29:1996;40-47.
6. Clark D.A., Sweeney G., Safe S., Hancock E., Kilburn D.G., Gauldie J. Cellular and genetic basis for suppression of cytotoxic T cell generation by haloaromatic hydrocarbons. Immunopharmacology. 6:(2):1983;143-153.
7. Davis D., Safe S. Immunosuppressive activities of polychlorinated dibenzofuran congeners quantitative structure-activity relationships and interactive effects . Toxicol. Appl. Pharmacol. 94:(1):1988;141-149.
8. De Krey G.K., Kerkvliet N.I. Suppression of cytotoxic T lymphocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin occurs in vivo, but not in vitro, and is independent of corticosterone elevation. Toxicology. 97:(1-3):1995;105-112.
9. Deeths M.J., Kedl R.M., Mescher M.F. CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J. Immunol. 163:(1):1999;102-110.
10. Eichelberger M.C., Wang M.L., Allan W., Webster R.G., Doherty P.C. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J. Gen. Virol. 72:(Pt 7):1991;1695-1698.
11. Flynn K.J., Belz G.T., Altman J.D., Ahmed R., Woodland D.L., Doherty P.C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity. 8:(6):1998;683-691.
12. Flynn K.J., Riberdy J.M., Christensen J.P., Altman J.D., Doherty P.C. In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc. Natl. Acad. Sci. USA. 96:(15):1999;8597-8602.
13. Fujimaki H., Nohara K., Kobayashi T., Suzuki K., Eguchi-Kasai K., Tsukumo S., Kijima M., Tohyama C. Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/Nga mice. Toxicol. Sci. 66:2002;117-124.
14. Givan A.L., Fisher J.L., Waugh M., Ernstoff M.S., Wallace P.K. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J. Immunol. Methods. 230:(1-2):1999;99-112.
15. Hinsdill R.D., Couch D.L., Speirs R.S. Immunosuppression in mice induced by dioxin (TCDD) in feed. J. Environ. Pathol. Toxicol. 4:(2-3):1980;401-425.
16. Holsapple M.P., Dooley R.K., McNerney P.J., McCay J.A. Direct suppression of antibody responses by chlorinated dibenzodioxins in cultured spleen cells from (C57BL/6 × C3H)F1 and DBA/2 mice. Immunopharmacology. 12:(3):1986;175-186.
17. Hou S., Doherty P.C. Partitioning of responder CD8+ T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J. Immunol. 150:(12):1993;5494-5500.
18. House R.V., Lauer L., Murray M. Examination of immune parameters and host resistance mechanisms in B6C3F1 mice following adult exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Toxicol. Environ. Health. 31:(3):1990;203-215.
19. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R.M., Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science. 259:(5102):1993;1742-1745.
20. Ito T., Inouye K., Fujimaki H., Tohyama C., Nohara K. Mechanism of TCDD-induced suppression of antibody production effect on T cell-derived cytokine production in the primary immune reaction of mice . Toxicol. Sci. 70:(1):2002;46-54.
21. Kerkvliet N.I. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int. Immunopharmacol. 2:(2-3):2002;277-291.
22. Kerkvliet N.I., Brauner J.A. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Environ. Res. 52:(2):1990;146-154.
23. Kerkvliet N.I., Baecher-Steppan L., Smith B., Youngberg J., Henderson M., Buhler D. Role of the Ah locus in suppression of cytotoxic T lymphocyte activity by halogenated aromatic hydrocarbons (PCBs and TCDD) structure-activity relationships and effects in C57B1/6 mice congenic at the Ah locus . Fundam. Appl. Toxicol. 14:(3):1990;532-541.
24. Kerkvliet N.I., Baecher-Steppan L., Shepher D.M., Oughton J.A., Vorderstrasse B.A., DeKrey G.K. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 157:(6):1996;2310-2319.
25. Kerkvliet N.I., Shepherd D.M., Baecher-Steppan L. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD . Toxicol. Appl. Pharmacol. 185:(2):2002;146-152.
26. Kohn M.C., Portier C.J. Effects of the mechanism of receptor-mediated gene expression on the shape of the dose-response curve. Risk Anal. 13:(5):1993;565-572.
27. Lang D.S., Becker S., Clark G.C., Devlin R.B., Koren H.S. Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro. Arch. Toxicol. 68:(5):1994;296-302.
28. Larsen J.C., Farland W., Winters D. Current risk assessment approaches in different countries. Food Addit. Contam. 17:(4):2000;359-369.
29. Lawrence B.P., Leid M., Kerkvliet N.I. Distribution and behavior of the Ah receptor in murine T lymphocytes. Toxicol. Appl. Pharmacol. 138:(2):1996;275-284.
30. Legge K.L., Braciale T.J. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity. 18:2003;265-277.
31. Levelt C.N., de Jong Y.P., Mizoguchi E., O'Farrelly C., Bhan A.K., Tonegawa S., Terhorst C., Simpson S.J. High- and low-affinity single-peptide/ MHC ligands have distinct effects on the development of mucosal CD8αα and CD8αβ T lymphocytes. Proc. Natl. Acad. Sci. USA. 96:1999;5628-5633.
32. Luebke R.W., Copeland C.B., Diliberto J.J., Akubue P.I., Andrews D.L., Riddle M.M., Williams W.C., Birnbaum L.S. Assessment of host resistance to Trichinella spiralis in mice following preinfection exposure to 2,3,7,8-TCDD. Toxicol. Appl. Pharmacol. 125:(1):1994;7-16.
33. Lundberg K., Dencker L., Gronvik K.O. 2,3,7,8-Tetrachlorodibenzo-p- dioxin (TCDD) inhibits the activation of antigen-specific T-cells in mice. Int. J. Immunopharmacol. 14:(4):1992;699-705.
34. Mamalaki C., Norton T., Tanaka Y., Townsend A.R., Chandler P., Simpson E., Kioussis D. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;11342-11346.
35. Mamalaki C., Elliott J., Norton T., Yannoutsos N., Townsend A.R., Chandler P., Simpson E., Kioussis D. Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev. Immunol. 3:(3):1993;159-174.
36. + T cells hyporesponsive to antigen. Toxicol. Sci. 74:2003;74-84.
37. Moskophidis D., Kioussis D. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 188:(2):1998;223-232.
38. Nguyen L., Knipe D.M., Finberg R.W. Mechanism of virus-induced Ig subclass shifts. J. Immunol. 152:(2):1994;478-484.
39. Nohara K., Fujimaki H., Tsukumo S., Inouye K., Sone H., Tohyama C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57B1/6 mice. Toxicology. 172:(1):2002;49-58.
40. Portier C., Tritscher A., Kohn M., Sewall C., Clark G., Edler L., Hoel D., Lucier G. Ligand/receptor binding for 2,3,7,8-TCDD implications for risk assessment . Fundam. Appl. Toxicol. 20:(1):1993;48-56.
41. Prell R.A., Dearstyne E., Steppan L.G., Vella A.T., Kerkvliet N.I. CTL hyporesponsiveness induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin role of cytokines and apoptosis . Toxicol. Appl. Pharmacol. 166:(3):2000;214-221.
42. Price G.E., Ou R., Jiang H., Huang L., Moskophidis D. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia. J. Exp. Med. 191:(11):2000;1853-1867.
43. Riberdy J.M., Christensen J.P., Branum K., Doherty P.C. Diminished primary and secondary influenza virus-specific CD8(+) T-cell responses in CD4-depleted Ig(-/-) mice. J. Virol. 74:(20):2000;9762-9765.
44. Ruby C.E., Leid M., Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells p50 homodimer activation is not affected . Mol. Pharmacol. 62:(3):2002;722-728.
45. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science. 248:(4961):1990;1349-1356.
46. Shepherd D.M., Dearstyne E.A., Kerkvliet N.I. The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4(+) T cells in adoptively-transferred mice. Toxicol. Sci. 56:(2):2000;340-350.
47. Shrikant P., Mescher M.F. Control of syngeneic tumor growth by activation of CD8+ T cells efficacy is limited by migration away from the site and induction of nonresponsiveness . J. Immunol. 162:(5):1999;2858-2866.
48. Sulentic C.E., Holsapple M.P., Kaminski N.E. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p- dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J. Pharmacol. Exp. Ther. 295:(2):2000;705-716.
49. Tham E.L., Mescher M.F. Signaling alterations in activation-induced nonresponsive CD8 T cells. J. Immunol. 167:(4):2001;2040-2048.
50. Tomar R.S., Kerkvliet N.I. Reduced T-helper cell function in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Lett. 57:(1):1991;55-64.
51. Tomonari K., Lovering E. T-cell receptor-specific monoclonal antibodies against a V beta 11-positive mouse T-cell clone. Immunogenetics. 28:(6):1988;445-451.
52. Topham D., Castrucci M., Wingo F., Belz G., Doherty P. The role of antigen in the localization of naive, acutely activated and memory CD8+ T cells to the lung during influenza pneumonia. J. Immunol. 167:2001;6983.
53. Tough D., Sprent J. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1994;127.
54. Tripp R.A., Hou S., Doherty P.C. Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. J. Immunol. 154:(11):1995;5870-5875.
55. Tucker A.N., Vore S.J., Luster M.I. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 29:(4):1986;372-377.
56. Vorderstrasse B.A., Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicol. Appl. Pharmacol. 171:(2):2001;117-125.
57. Vorderstrasse B.A., Bohn A.A., Lawrence B.P. Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD. Toxicology. 188:2003;15-28.
58. Wack A., Corbella P., Harker N., Crispe I.N., Kioussis D. Multiple sites of postactivation CD8+ T cell disposal. Eur. J. Immunol. 27:1997;577-583.
59. Warren T.K., Mitchell K.A., Lawrence B.P. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol. Sci. 56:(1):2000;114-123.
60. Wells M.A., Albrecht P., Ennis F.A. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J. Immunol. 126:(3):1981;1036-1041.
61. Wiley J., Hogan R., Woodland D., Harmsen A. Antigen-specific CD8+ T cells persist in the upper respiratory tract following influenza virus infection. J. Immunol. 167:2001;3293.
62. Wood S.C., Holsapple M.P. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD. Toxicol. Appl. Pharmacol. 122:(2):1993;308-313.